MAP1A and Alzheimer disease: Our results showed that both hemoglobin α and MAP1A (Microtubule-associated protein 1A) were altered by estradiol treatments, but theMAP1A response in the mouse brain was specific to early, not late, treatment, suggesting that MAP1A expression is related to the “critical window” of HT on AD.